| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.005 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |